Prostate cancer spurs new nerves

	Tweet

Prostate cancer – and perhaps other cancers – promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research.

Previous research showed that prostate cancer follows the growth of nerves, but this is the first time that scientists have demonstrated that the tumors actually promote nerve growth.

“This is the first report of this phenomenon,” said Dr. Gustavo Ayala, professor of pathology and urology at BCM and first author of the article. “It represents an important new target in prostate cancer treatment, as prostate cancers are more aggressive when neurogenesis is present.”

Ayala noted that this finding is comparable to the discovery of angiogenesis or the growth of new blood vessels. Both are part of the wound repair process.

“We also believe that axongenesis and neurogenesis is found not only in prostate cancer, but is potentially a more global phenomenon, particularly relating to those cancers that grow along nerve paths,” said Ayala, also a researcher in the Dan L. Duncan Cancer Center at BCM.

Ayala and his colleagues studied the neurogenesis in tissue culture, in human tissues of patients who had had prostate cancer and compared to prostate tissues from patients who had died of other ailments. They calculated the density of nerves in human prostate tissues, including those with prostate cancer. They found that nerve density was considerably higher in patients with prostate cancer and in precancerous lesions. As part of the study, he used an entire prostate gland to reconstruct the prostate and enable scientists to see the growth of nerves and axons in three-dimensions, a computerized process that took substantial continuous computer processing.

He and his colleagues have even identified a possible method of regulating the growth of new nerves and axons through a protein called semaphorin 4F. Semaphorins are embryologically active molecules that regulate nerve growth and direction. Most disappear in adults, but semaphoring 4F is active in wound repair. When prostate cancer cells overproduce semaphorin 4F, new nerves result. Blocking semaphoring 4F prevents the growth of new nerves.

###

Others who took part in this research include: Hong Dai, Michael Powell, Rile Li, Yi Ding, Thomas M. Wheeler, David Shine, Timothy Thompson, Dov Kadmon, BrianJ. Miles, Michael M. Ittmann and David Rowley, all of BCM. Thompson is now with The University of Texas M.D. Anderson Cancer Center.

Funding for this research came from the National Institutes of Health and the Tumor Microenvironment Network of the National Cancer Institute.

Contact: Glenna Picton

713-798-4710
Baylor College of Medicine

RELATED STORIES:
For men with prostate cancer, treatment information fails to address fears   Model of Prostate Cancer Helps Identify Promising Pain Treatment   New drug targets vitamin D receptors in hormone resistant prostate cancers   Prostate technique provides new insights   Heavy men fare poorly with prostate cancer   Moderate exercise may lower prostate cancer risk   Obesity linked with higher prostate cancer risk   New Study Strengthens Association of Prostate Cancer with Exposure to Agent Orange in Vietnam Vetera   Vitamin D could provide beneficial treatment to prostate cancer   Prostate cancer risk increased in obese men: study   Infertility linked to prostate cancer   Prostate Cancer Clinical Findings   Strict diet program may help prostate cancer   Curry Spice Component May Help Slow Prostate Tumor Growth   Barbecue meats linked with prostate cancer   Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear   Exercise Reduces Death Rate in Prostate Cancer Patients   Common genetic prostate cancer variant identified   First Biomarker Discovered that Predicts Prostate Cancer Outcome   Prostate cancer therapy linked to bone loss   Prostate cancer vaccine improves survival   Screening spares men from advanced prostate cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]